MacuLogix is a pioneer in the early detection and tracking of age-related macular degeneration (AMD). MacuLogix’ AdaptDx™ has received FDA 510(k) clearance for measurement of dark adaptation function and patient testing has been completed to support validation as a diagnostic for AMD. However, the AdaptDx™ is not currently cleared for sale as a diagnostic. In addition, the AdaptDx™ is being used by a number of pharmaceutical companies in the development of drugs for early AMD.
|
|
|
|
|
11-50 employees
View all MacuLogix employees
|
|
|
IT Services and IT Consulting
|
|
|
717-583-1220
|
|
|
Hummelstown, Pennsylvania
|
|
|
2004
|
The decision makers in MacuLogix are Dave Miller, Harold Mapes, Will Urey, etc. Click to Find MacuLogix decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.